147 References Smits, J. A. J., Rosenfield, D., Otto, M. W., Powers, M. B., Hofmann, S. G., Telch, M. J., … Tart, C. D. (2013b). D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: Evidence from the treatment of height phobia. Biological Psychiatry, 73(11), 1054–1058. https://doi.org/10.1016/j.biopsych.2012.12.009 Smits, J. A., Julian, K., Rosenfield, D., & Powers, M. B. (2012). Threat Reappraisal as a Mediator of Symptom Change in Cognitive-Behavioral Treatment of Anxiety Disorders: A Systematic Review. Journal of Consulting and Clinical Psychology, 80(4), 624–635. Soravia, L. M., Heinrichs, M., Aerni, A., Maroni, C., Schelling, G., Ehlert, U., … de Quervain, D. J.-F. (2006). Glucocorticoids reduce phobic fear in humans. Proceedings of the National Academy of Sciences, 103(14), 5585–5590. https://doi.org/10.1073/pnas.0509184103 Spence, S. H., & Rapee, R. M. (2016). The etiology of social anxiety disorder: An evidence-based model. Behaviour Research and Therapy, 86, 50–67. https://doi.org/10.1016/j.brat.2016.06.007 Stålenheim, E. G., Eriksson, E., von Knorring, L., & Wide, L. (1998). Testosterone as a biological marker in psychopathy and alcoholism. Psychiatry Research, 77(2), 79–88. https://doi.org/https://doi. org/10.1016/S0165-1781(97)00143-1 Stanton, S. J., & Schultheiss, O. C. (2009). The hormonal correlates of implicit power motivation. Journal of Research in Personality, 43(5), 942–949. https://doi.org/10.1016/j.jrp.2009.04.001 Steenen, S. A., Van Wijk, A. J., Van Der Heijden, G. J. M. G., Van Westrhenen, R., De Lange, J., & De Jongh, A. (2016). Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. Journal of Psychopharmacology, 30(2), 128–139. https://doi.org/10.1177/0269881115612236 Stein, M. B., & Stein, D. J. (2008). Social anxiety disorder. The Lancet, 371(9618), 1115–1125. https:// doi.org/https://doi.org/10.1016/S0140-6736(08)60488-2 Struijs, S. Y., Lamers, F., Rinck, M., Roelofs, K., Spinhoven, P., & Penninx, B. W. J. H. (2018). The predictive value of Approach and Avoidance tendencies on the onset and course of depression and anxiety disorders. Depression and Anxiety, 35(6), 551–559. https://doi.org/10.1002/da.22760 Struijs, S. Y., Lamers, F., Vroling, M. S., Roelofs, K., Spinhoven, P., & Penninx, B. W. J. H. (2017). Approach and avoidance tendencies in depression and anxiety disorders. Psychiatry Research, 256(July), 475–481. https://doi.org/10.1016/j.psychres.2017.07.010 Tarvainen, M. P., Niskanen, J. P., Lipponen, J. A., Ranta-aho, P. O., & Karjalainen, P. A. (2014). Kubios HRV - Heart rate variability analysis software. Computer Methods and Programs in Biomedicine, 113(1), 210–220. https://doi.org/10.1016/j.cmpb.2013.07.024 Taylor, C. T., & Amir, N. (2012). Modifying automatic approach action tendencies in individuals with elevated social anxiety symptoms. Behaviour Research and Therapy, 50(9), 529–536. https:// doi.org/10.1016/j.brat.2012.05.004 Telch, M. J., Bruchey, A. K., Rosenfield, D., Cobb, A. R., Smits, J., Pahl, S., & Gonzalez-Lima, F. (2014). Effects of Post-Session Administration of Methylene Blue on Fear Extinction and Contextual Memory in Adults With Claustrophobia. American Journal of Psychiatry, 171(10), 1091–1098. https://doi.org/10.1176/appi.ajp.2014.13101407 Terburg, D., Morgan, B., & van Honk, J. (2009). The testosterone-cortisol ratio: A hormonal marker for proneness to social aggression. International Journal of Law and Psychiatry, 32(4), 216–223. https://doi.org/10.1016/j.ijlp.2009.04.008
RkJQdWJsaXNoZXIy MTk4NDMw